Coland Holdings Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Coland Holdings Limited with three other
companies in this sector in China:
Zhejiang Starry Pharmaceutical Co Ltd
sales of 672.75 million Chinese Renmimbi [US$102.18 million]
of which 99%
was Pharmaceuticals Industry),
Ginwa Enterprise Group Inc.
(666.08 million Chinese Renmimbi [US$101.16 million]
of which 73%
was Pharmaceutical Industry), and
Shanghai Fudan Forward S&T Co Ltd
(670.57 million Chinese Renmimbi [US$101.85 million]
of which 56%
Coland Holdings Limited reported sales of 675.24 million Chinese Renmimbi (US$102.56 million)
December of 2016.
increase of 26.8%
versus 2015, when the company's sales were 532.41 million Chinese Renmimbi.
Sales at Coland Holdings Limited have increased during each of the previous five years
(and since 2011, sales have increased a total of 105%).